Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
error bars indicate s.d
Su2057: a genetic risk score associated with nausea resulting from GLP-1 receptor agonist treatment: a post-hoc analysis of a randomized controlled trial of liraglutide
It belongs to a novel class of agents known as triple receptor agonists, meaning it simultaneously activates three distinct hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Reproduction 124 , 683689 (2002)
doi: 10.2196/19896, 43
US$ 24.90
US$ 20.07
US$ 21.41
US$ 22.04
US$ 21.88
US$ 20.10
US$ 21.53
US$ 22.04
US$ 27.98
